Compounds > gadolinium 1,4,7,10-tetraazacyclododecane-n,n',n'',n'''-tetraacetate
Page last updated: 2024-09-03

gadolinium 1,4,7,10-tetraazacyclododecane-n,n',n'',n'''-tetraacetate and Muscle Disorders

gadolinium 1,4,7,10-tetraazacyclododecane-n,n',n'',n'''-tetraacetate has been researched along with Muscle Disorders in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's2 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Hodler, J; Marincek, B; Orellano, J; Thurnher, S; von Schulthess, GK1
Alanen, A; Dean, PB; Kormano, M; Määttänen, H; Niemi, P; Paajanen, H1

Other Studies

2 other study(ies) available for gadolinium 1,4,7,10-tetraazacyclododecane-n,n',n'',n'''-tetraacetate and Muscle Disorders

ArticleYear
[Gd-DOTA in musculoskeletal diseases].
    RoFo : Fortschritte auf dem Gebiete der Rontgenstrahlen und der Nuklearmedizin, 1990, Volume: 153, Issue:5

    Topics: Adolescent; Adult; Aged; Aged, 80 and over; Bone Diseases; Contrast Media; Female; Gadolinium; Heterocyclic Compounds; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Muscular Diseases; Organometallic Compounds

1990
MR imaging of experimental intramuscular hemorrhage at 0.02 T. Contrast enhancement with Gd-DOTA.
    Acta radiologica (Stockholm, Sweden : 1987), 1990, Volume: 31, Issue:5

    Topics: Animals; Hemorrhage; Heterocyclic Compounds; Magnetic Resonance Imaging; Muscular Diseases; Organometallic Compounds; Rabbits; Radiographic Image Enhancement

1990